Astrana Health (NASDAQ:ASTH – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.28 to $1.52 for the period, compared to the consensus estimate of $1.60. The company issued revenue guidance of $1.65 billion to $1.85 billion, compared to the consensus revenue estimate of $1.76 billion.
Astrana Health Stock Down 1.0 %
Shares of ASTH stock traded down $0.39 on Tuesday, reaching $37.93. The company had a trading volume of 125,521 shares, compared to its average volume of 153,978. The firm has a market capitalization of $2.13 billion, a PE ratio of 28.74, a PEG ratio of 1.20 and a beta of 1.12. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11. The firm has a 50-day simple moving average of $40.47. Astrana Health has a one year low of $28.86 and a one year high of $45.71.
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.17 by $0.09. The business had revenue of $353.00 million during the quarter, compared to the consensus estimate of $341.17 million. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm’s revenue was up 20.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.02 EPS. On average, sell-side analysts forecast that Astrana Health will post 1.65 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on ASTH
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
- Five stocks we like better than Astrana Health
- Dividend Capture Strategy: What You Need to Know
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is a SEC Filing?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Stock Dividend Cuts Happen Are You Ready?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.